![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Publication history |
Reprints |
Permissions |
Cite this article as |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
ORIGINAL ARTICLE
Minerva Anestesiologica 2022 January-February;88(1-2):8-15
DOI: 10.23736/S0375-9393.21.15734-7
Copyright © 2021 EDIZIONI MINERVA MEDICA
language: English
Effects of dexmedetomidine on glucose-related hormones and lactate in non-diabetic patients under general anesthesia: a randomized controlled trial
Wei ZHOU 1, Jiahua WANG 1, 2, Dawei YANG 1, Shunping TIAN 1, Chao TAN 2, Yang YANG 1, Wei SUI 1, Jianhong SUN 1, Zhuan ZHANG 1 ✉
1 Department of Anesthesiology, The Affiliated Hospital of Yangzhou University, Yangzhou, China; 2 School of Medicine, Yangzhou University, Yangzhou, China
BACKGROUND: The aim of this study was to explore the effects of dexmedetomidine on glucose-related hormones and lactate levels in non-diabetic patients undergoing malignant gastrointestinal tumor radical resection.
METHODS: Groups D
RESULTS: Compared with group C, glucose levels increased in group D
CONCLUSIONS: Dexmedetomidine loading dose 1 µg/kg and maintenance dose 0.25 µg/kg/h produces a stable insulin level and significant postoperative decreases in glucagon, cortisol, epinephrine and norepinephrine secretion with stable maintenance of intraoperative and postoperative blood glucose levels and decreased postoperative lactate levels in non-diabetic patients under general anesthesia.
KEY WORDS: Dexmedetomidine; Glucose; Hormones; Lactates; Insulin